Literature DB >> 7300592

Effects of clofibrate and tiadenol on the elimination of lipids and bile acids in rat bile.

P Cuchet, C Morrier, F Cand, C Keriel.   

Abstract

The aim of the work presented here was to compare the biliary elimination of cholesterol and the different bile acids of rats that had been made hypolipidemic by short-term treatments with clofibrate or tiadenol. Both treatments induced a significant decrease in cholesterol output in the bile. The analysis of the different bile acids showed a decrease in dihydroxylated acids elimination (especially CDC acid) without any difference between the 2 sexes. This decrease was associated with an increase in cholic acid excretion. These results are directly correlated with the dose of the administered hypolipidemic drug. The drugs caused as significant increase in the ratio of trihydroxylated acids of the bile and on the output was obtained, for both drugs, with a treatment of 200 mg/kg/day. Clofibrate had a greater effect than tiadenol at this dose. Both drugs show a greater effect on lowering serum lipid levels in female animals when compared to males, whereas elimination of bile cholesterol and modifications of bile acids were greater in male animals than female animals.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7300592     DOI: 10.1007/bf02535340

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  34 in total

1.  REDUCTION OF SERUM TRIGLYCERIDES AND CHOLESTEROL BY ETHYL P-CHLOROPHENOXY-ISOBUTYRATE (CPIB).

Authors:  M M BEST; C H DUNCAN
Journal:  Am J Cardiol       Date:  1965-02       Impact factor: 2.778

2.  EFFECTS OF ALPHA-P-CHLOROPHENOXYISOBUTYRYL ETHYL ESTER (CPIB) WITH AND WITHOUT ANDROSTERONE ON CHOLESTEROL BIOSYNTHESIS IN RAT LIVER.

Authors:  D R AVOY; E A SWYRYD; R G GOULD
Journal:  J Lipid Res       Date:  1965-07       Impact factor: 5.922

3.  [The effect of tiadenol on type IIA hyperlipidemias].

Authors:  J L de Gennes; J Truffert; J M Le Quere
Journal:  Therapie       Date:  1976 Jul-Aug       Impact factor: 2.070

4.  Effects of clofibrate on some microsomal hydroxylations involved in the formation and metabolism of bile acids in rat liver.

Authors:  B O Angelin; I Björkhem; K Einarsson
Journal:  Biochem J       Date:  1976-05-15       Impact factor: 3.857

5.  [Histological and ultrastuctural study of the rat liver following subacute administration of a new hypolipemic agent, bis-(hydroxy-ethyl-thio) 1-10 decane].

Authors:  E Martin; G Feldmann
Journal:  Pathol Biol (Paris)       Date:  1974-02

6.  Effects of chlorophenoxyisobutyrate on the synthesis and metabolism of cholesterol in man.

Authors:  H S Sodhi; B J Kudchodkar; L Horlick; C H Weder
Journal:  Metabolism       Date:  1971-04       Impact factor: 8.694

7.  [Effect of tiadenol in prolonged therapy of hyperlipoproteinemias (type IIa-IIb)].

Authors:  J Rouffy
Journal:  Therapie       Date:  1975 Nov-Dec       Impact factor: 2.070

8.  Action of tiadenol and clofibrate on biliary excretions of cholesterol and bile salts in rats.

Authors:  G Fredj; M Clenet; P Cuchet; F Rousselet; C Rozé
Journal:  Digestion       Date:  1979       Impact factor: 3.216

9.  The effects of tiadenol, clofibrate and clofibride on bile composition in the rat.

Authors:  C Rozé; P Cuchet; M Souchard; C Vaille; C Debray
Journal:  Eur J Pharmacol       Date:  1977-05-01       Impact factor: 4.432

10.  Response of hepatic microbodies to a hypolipidemic agent, ethyl chlorophenoxyisobutyrate (CPIB).

Authors:  D J Svoboda; D L Azarnoff
Journal:  J Cell Biol       Date:  1966-08       Impact factor: 10.539

View more
  1 in total

1.  Modulation of fatty acid-binding protein content of adult rat heart in response to chronic changes in plasma lipid levels.

Authors:  A Garnier; C Poizat; C Keriel; P Cuchet; M M Vork; Y F de Jong; J F Glatz
Journal:  Mol Cell Biochem       Date:  1993 Jun 9-23       Impact factor: 3.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.